Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Qiang Yu, Liwei Wu, Jie Ji, Jiao Feng, Weiqi Dai, Jingjing Li, Jianye Wu & Chuanyong Guo. (2020) Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 7, pages 271-288.
Read now
Read now
Ahmed Omar Kaseb. (2018) Editorial: charting the future of hepatocellular carcinoma publications. Journal of Hepatocellular Carcinoma 5, pages 51-54.
Read now
Read now
Danijel Galun, Tatjana Srdic-Rajic, Aleksandar Bogdanovic, Zlatibor Loncar & Marinko Zuvela. (2017) Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies. Journal of Hepatocellular Carcinoma 4, pages 93-103.
Read now
Read now
Amit K Keshari, Ashok K Singh, Umesh Kumar, Vinit Raj, Amit Rai, Pranesh Kumar, Dinesh Kumar, Biswanath Maity, Sneha Nath, Anand Prakash & Sudipta Saha. (2017) 5H-benzo[h]thiazolo[2,3-b]quinazolines ameliorate NDEA-induced hepatocellular carcinogenesis in rats through IL-6 downregulation along with oxidative and metabolic stress reduction. Drug Design, Development and Therapy 11, pages 2981-2995.
Read now
Read now
Pravinkumar Vishwanath Ingle, Sarah Zakiah Samsudin, Pei Qi Chan, Mei Kei Ng, Li Xuan Heng, Siu Ching Yap, Amy Siaw Hui Chai & Audrey San Ying Wong. (2016) Development and novel therapeutics in hepatocellular carcinoma: a review. Therapeutics and Clinical Risk Management 12, pages 445-455.
Read now
Read now
Articles from other publishers (61)
Amna Amin Sethi & Nisar Ahmed Shar. (2023) Identification of Liver Cancer Driver Mutations from COSMIC Data. International Journal of Cancer Management 16:1.
Crossref
Crossref
Cemalettin Koc, Sami Akbulut, Kemal Baris Sarici, Muhammed Mehdi Uremis, Ufuk Gunay Dogan, Zeynep Kucukakcali, Ibrahim Umar Garzali, Ertugrul Karabulut, Yusuf Turkoz & Sezai Yilmaz. (2023) Measurement of Heavy Metal and Antioxidant-Oxidant Levels in Tissues Obtained From Three Different Localizations of Explant Hepatectomy of Patients With Hepatocellular Carcinoma. Transplantation Proceedings.
Crossref
Crossref
Ge Gao & Xuke Luan. (2022) Diagnostic performance of clusterin in hepatocellular carcinoma: A meta-analysis. The International Journal of Biological Markers 37:4, pages 404-411.
Crossref
Crossref
Ann‐Sofi Duberg, Charlotte Lybeck, Anna Fält, Scott Montgomery & Soo Aleman. (2022) Reply. Hepatology Communications 6:12, pages 3593-3594.
Crossref
Crossref
Kimia Falamarzi, Mahdi Malekpour, Mobin Fallah Tafti, Negar Azarpira, Mehrdad Behboodi & Mohammad Zarei. (2022) The role of FGF21 and its analogs on liver associated diseases. Frontiers in Medicine 9.
Crossref
Crossref
Eduard Jonas, Marc Bernon, Barbara Robertson, Chris Kassianides, Elie Keli, Kwaku Offei Asare, Isaac Olusegun Alatise, Michael Okello, Nana Oumarou Blondel, Kenedy Ondede Mulehane, Zeki Abdurahman Abubeker, Alaaeldin Awad Nogoud, Pueya Rashid Nashidengo, Onesai Chihaka, Christian Tzeuton, Geoffrey Dusheiko, Mark Sonderup & C Wendy Spearman. (2022) Treatment of hepatocellular carcinoma in sub-Saharan Africa: challenges and solutions. The Lancet Gastroenterology & Hepatology 7:11, pages 1049-1060.
Crossref
Crossref
C Wendy Spearman, Geoffrey Dusheiko, Eduard Jonas, Abdelmounem Abdo, Mary Afihene, Lina Cunha, Hailemichael Desalegn, Chris Kassianides, Leolin Katsidzira, Anna Kramvis, Philip Lam, Olufunmilayo A Lesi, Eileen A Micah, Emmanuel Musabeyezu, Gibril Ndow, Chidi V Nnabuchi, Ponsiano Ocama, Edith Okeke, John Rwegasha, Abate B Shewaye, Fatuma F Some, Christian Tzeuton & Mark W Sonderup. (2022) Hepatocellular carcinoma: measures to improve the outlook in sub-Saharan Africa. The Lancet Gastroenterology & Hepatology 7:11, pages 1036-1048.
Crossref
Crossref
Song Ge, Chen-rui Xu, Yan-ming Li, Yu-lin Zhang, Na Li, Fei-tong Wang, Liang Ding & Jian Niu. (2022) Identification of the Diagnostic Biomarker VIPR1 in Hepatocellular Carcinoma Based on Machine Learning Algorithm. Journal of Oncology 2022, pages 1-13.
Crossref
Crossref
Derya Korkmaz, Petek Konya & Neşe Demirtürk. (2022) Investigation of the Characteristics of Crimean Congo Hemorrhagic Fever Cases Reported in Afyonkarahisar Province. Turkish Journal of Parasitology 46:3, pages 224-227.
Crossref
Crossref
Ann‐Sofi Duberg, Charlotte Lybeck, Anna Fält, Scott Montgomery & Soo Aleman. (2022) Chronic hepatitis B virus infection and the risk of hepatocellular carcinoma by age and country of origin in people living in Sweden: A national register study. Hepatology Communications 6:9, pages 2418-2430.
Crossref
Crossref
Ganesh Manudhane, Ria Mehta, Shamshersingh Chauhan & Maharudra Kumbhar. (2022) Management of Acute Coronary Syndrome With a Bleeding Intra-Tumoral Hepatocellular Carcinoma: A Case Report. Cureus.
Crossref
Crossref
Camille Péneau, Sandrine Imbeaud, Tiziana La Bella, Theo Z Hirsch, Stefano Caruso, Julien Calderaro, Valerie Paradis, Jean-Frederic Blanc, Eric Letouzé, Jean-Charles Nault, Giuliana Amaddeo & Jessica Zucman-Rossi. (2022) Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma. Gut 71:3, pages 616-626.
Crossref
Crossref
Konstantinos Arvanitakis, Triantafyllia Koletsa, Ioannis Mitroulis & Georgios Germanidis. (2022) Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy. Cancers 14:1, pages 226.
Crossref
Crossref
BoZhi Liu, YongChao Zhang, Hui Chen, Wei Li & Emmanuel Tsochatzis. (2022) The combination of transcatheter arterial chemoembolisation (TACE) and thermal ablation versus TACE alone for hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2022:1.
Crossref
Crossref
GhaidaA Almasaad, MohammedA Alkarbi, WeamS Hussein, Faisal Al-Alem, AhmadM Madkhali, AbdulazizA Bazuhair & MazenM Hassanain. (2022) Hepatocellular carcinoma in a healthy liver; Case report and literature review. Saudi Journal of Laparoscopy 7:1, pages 21.
Crossref
Crossref
Maissa El Raziky, Hanan Abdel Hafez, Aisha Elsharkawy, Tarek Ahmed Moneer, Suzan M. EL-Sheikh, Rabab M. Maher & Sahar A. Sharaf. (2021) Serum level of cytokeratin 19 as a diagnostic and prognostic marker in patients with HCV-related hepatocellular carcinoma. Egyptian Liver Journal 11:1.
Crossref
Crossref
Fariborz Mansour-Ghanaei, Farahnaz Joukar, Mohammadreza Naghipour, Soheil Hassanipour, Sara Yeganeh, Masood Sepehrimanesh & Mohammad Fathalipour. (2021) Epidemiologic profile of viral hepatitis B and C in North of Iran: results from PERSIAN Guilan Cohort Study (PGCS). BMC Research Notes 14:1.
Crossref
Crossref
Xiangpeng Hu, Dan Han, Yanyan Wang, Jiong Gu, Xian Wang, Yufeng Jiang, Yan Yang & Jun Liu. (2021) Phospho-Smad3L promotes progression of hepatocellular carcinoma through decreasing miR-140-5p level and stimulating epithelial-mesenchymal transition. Digestive and Liver Disease 53:10, pages 1343-1351.
Crossref
Crossref
Anshuly Tiwari, Siddharth J. Modi, Satish Y. Gabhe & Vithal M. Kulkarni. (2021) Evaluation of piperine against cancer stem cells (CSCs) of hepatocellular carcinoma: Insights into epithelial-mesenchymal transition (EMT). Bioorganic Chemistry 110, pages 104776.
Crossref
Crossref
Yu-Fei Zhao, Xiu Xiong, Kai Chen, Wei Tang, Xu Yang & Zheng-Rong Shi. (2021) Evaluation of the Therapeutic Effect of Adjuvant Transcatheter Arterial Chemoembolization Based on Ki67 After Hepatocellular Carcinoma Surgery. Frontiers in Oncology 11.
Crossref
Crossref
Lu Deng, Chang Wang, Chao He & Li Chen. (2021) Bone mesenchymal stem cells derived extracellular vesicles promote TRAIL-related apoptosis of hepatocellular carcinoma cells via the delivery of microRNA-20a-3p. Cancer Biomarkers 30:2, pages 223-235.
Crossref
Crossref
Magdalena Stepien, Pekka Keski‐Rahkonen, Agneta Kiss, Nivonirina Robinot, Talita Duarte‐Salles, Neil Murphy, Gabriel Perlemuter, Vivian Viallon, Anne Tjønneland, Agnetha Linn Rostgaard‐Hansen, Christina C. Dahm, Kim Overvad, Marie‐Christine Boutron‐Ruault, Francesca Romana Mancini, Yahya Mahamat‐Saleh, Krasimira Aleksandrova, Rudolf Kaaks, Tilman Kühn, Antonia Trichopoulou, Anna Karakatsani, Salvatore Panico, Rosario Tumino, Domenico Palli, Giovanna Tagliabue, Alessio Naccarati, Roel C.H. Vermeulen, Hendrik Bastiaan Bueno‐de‐Mesquita, Elisabete Weiderpass, Guri Skeie, Jose Ramón Quirós, Eva Ardanaz, Olatz Mokoroa, Núria Sala, Maria‐Jose Sánchez, José María Huerta, Anna Winkvist, Sophia Harlid, Bodil Ohlsson, Klas Sjöberg, Julie A. Schmidt, Nick Wareham, Kay‐Tee Khaw, Pietro Ferrari, Joseph A. Rothwell, Marc Gunter, Elio Riboli, Augustin Scalbert & Mazda Jenab. (2020) Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study. International Journal of Cancer 148:3, pages 609-625.
Crossref
Crossref
留馨 周. (2021) Clinical Features and Risk Factors of Extrahepatic Metastases from Primary Liver Cancer. Advances in Clinical Medicine 11:12, pages 6024-6030.
Crossref
Crossref
Siddharth J. Modi, Anshuly Tiwari & Vithal M. Kulkarni. (2021) Reversal of TGF-β-induced epithelial–mesenchymal transition in hepatocellular carcinoma by sorafenib, a VEGFR-2 and Raf kinase inhibitor. Current Research in Pharmacology and Drug Discovery 2, pages 100014.
Crossref
Crossref
Tekeba Sisay & Mezgebu Abunie. (2020) The potential of circulating tumor DNA to use as a molecular marker to screen and diagnose hepatocellular carcinoma: A systematic review. IP Journal of Diagnostic Pathology and Oncology 5:4, pages 361-368.
Crossref
Crossref
Qi Xia, Zheyue Shu, Ting Ye & Min Zhang. (2020) Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma. Frontiers in Genetics 11.
Crossref
Crossref
Di Zhou, Yi Dian Yang, Long Yang Jin, Yong Yang, Shou Hua Wang, Qiang Cai, Wen Bin Guan, Fei Ma & Liqin Xiong. (2020)
Near-Infrared Polymer Dots in the Portal-Hepatic Circulation Achieve Localization of Hepatic Carcinoma
In Vivo
. ACS Applied Bio Materials 3:9, pages 6177-6186.
Crossref
Crossref
Refika Sultan Dogan, Samed Saka & Burcu Bakir Gungor. (2020) Investigation of Hepatocellular Carcinoma Molecular Mechanisms via in Silico Analyses. Investigation of Hepatocellular Carcinoma Molecular Mechanisms via in Silico Analyses.
Sharda Yadav, Navid Kashaninejad & Nam-Trung Nguyen. (2020) RhoA and Rac1 in Liver Cancer Cells: Induction of Overexpression Using Mechanical Stimulation. Micromachines 11:8, pages 729.
Crossref
Crossref
Xiao Wei Ji, Yu Jiang, Hua Wu, Peng Zhou, Yu Ting Tan, Hong Lan Li, Lei Zhang, Wen Sui Zhao, Qing Hua Xia, Freddie Bray & Yong Bing Xiang. (2020) Long‐term liver cancer incidence and mortality trends in the Changning District of Shanghai, China. Journal of Digestive Diseases 21:4, pages 230-236.
Crossref
Crossref
Jiuwei ZhangYaodong ChenJing LinRuimei JiaTingting AnTianxiu DongYu ZhangXiuhua Yang. (2020)
Cyclovirobuxine D Exerts Anticancer Effects by Suppressing the
EGFR-FAK-AKT/ERK1/2-Slug
Signaling Pathway in Human Hepatocellular Carcinoma
. DNA and Cell Biology 39:3, pages 355-367.
Crossref
Crossref
Xue-Qing Yao, Ling Li, Long-Zhen Piao, Guang-Jian Zhang, Xue-Zhu Huang, Ying Wang & Zhe-Long Liang. (2020) Overexpression of Ubiquitin-Specific Protease15 (USP15) Promotes Tumor Growth and Inhibits Apoptosis and Correlated With Poor Disease-Free Survival in Hepatocellular Carcinoma. Technology in Cancer Research & Treatment 19, pages 153303382096745.
Crossref
Crossref
William B. Coleman. 2020. Essential Concepts in Molecular Pathology. Essential Concepts in Molecular Pathology
55
80
.
Sheng Zhang, Jing Lin, Jiakai Jiang, Yu Chen, Weifeng Tang & Longgen Liu. (2019) Association between methylenetetrahydrofolate reductase tagging polymorphisms and susceptibility of hepatocellular carcinoma: a case–control study. Bioscience Reports 39:11.
Crossref
Crossref
Salah M. Aly, Hamdy A. Fetaih, Abeer A. I. Hassanin, Mosleh M. Abomughaid & Aliaa A. Ismail. (2019) Protective Effects of Garlic and Cinnamon Oils on Hepatocellular Carcinoma in Albino Rats. Analytical Cellular Pathology 2019, pages 1-15.
Crossref
Crossref
Cailin C. Harro, Rebecca C. Smedley, John P. Buchweitz & Daniel K. Langlois. (2019) Hepatic copper and other trace mineral concentrations in dogs with hepatocellular carcinoma. Journal of Veterinary Internal Medicine 33:5, pages 2193-2199.
Crossref
Crossref
Beuy Joob & Viroj Wiwanitkit. (2021) Expected Hepatocarcinoma Cancer Rate Due to Escape Mutant among Local Population in Thailand: The Situation after the Implementation of Universal Hepatitis B Vaccination at Birth. Indian Journal of Medical and Paediatric Oncology 40:S 01, pages S16-S17.
Crossref
Crossref
BoZhi Liu, Hui Chen & Wei Li. (2019) The combination of transcatheter arterial chemoembolisation (TACE) and thermal ablation versus TACE alone for hepatocellular carcinoma. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Theodore J. Wigle, Elena V. Tsvetkova, Stephen A. Welch & Richard B. Kim. (2019) DPYD and Fluorouracil-Based Chemotherapy: Mini Review and Case Report. Pharmaceutics 11:5, pages 199.
Crossref
Crossref
Roseane Guimarães Ferreira, Magda Vieira Cardoso, Karine Maria de Souza Furtado, Kaio Murilo Monteiro Espíndola, Ruanderson Pereira Amorim & Marta Chagas Monteiro. (2019) Epigenetic alterations caused by aflatoxin b1: a public health risk in the induction of hepatocellular carcinoma. Translational Research 204, pages 51-71.
Crossref
Crossref
David Bovard, Antonin Sandoz, Karsta Luettich, Stefan Frentzel, Anita Iskandar, Diego Marescotti, Keyur Trivedi, Emmanuel Guedj, Quentin Dutertre, Manuel C. Peitsch & Julia Hoeng. (2018) A lung/liver-on-a-chip platform for acute and chronic toxicity studies. Lab on a Chip 18:24, pages 3814-3829.
Crossref
Crossref
K. Okrah, S. Tarighat, B. Liu, H. Koeppen, M. C. Wagle, G. Cheng, C. Sun, A. Dey, M. T. Chang, T. Sumiyoshi, Z. Mounir, C. Cummings, G. Hampton, L. Amler, J. Fridlyand, P. S. Hegde, S. J. Turley, M. R. Lackner & S. M. Huang. (2018) Transcriptomic analysis of hepatocellular carcinoma reveals molecular features of disease progression and tumor immune biology. npj Precision Oncology 2:1.
Crossref
Crossref
Jun Fu, Yanyan Li, Zhanzhan Li & Na Li. (2018) Clinical utility of decarboxylation prothrombin combined with α-fetoprotein for diagnosing primary hepatocellular carcinoma. Bioscience Reports 38:5.
Crossref
Crossref
Yuntao Bing, Maolin Tian, Gang Li, Bin Jiang, Zhaolai Ma, Lei Li, Liang Wang, Hangyan Wang & Dianrong Xiu. (2018) Down-regulated of PCDH10 predicts poor prognosis in hepatocellular carcinoma patients. Medicine 97:35, pages e12055.
Crossref
Crossref
Shuhong Kong, Xuewang Yue, Sheng Kong & Yujie Ren. (2018) Application of contrast‑enhanced ultrasound and enhanced CT in diagnosis of liver cancer and evaluation of radiofrequency ablation. Oncology Letters.
Crossref
Crossref
Hengyu Zhou, Ying Cai, Dina Liu, Menghui Li, Yu Sha, Wenlu Zhang, Kai Wang, Jianping Gong, Ni Tang, Ailong Huang & Jie Xia. (2018)
Pharmacological or transcriptional inhibition of both HDAC1 and 2 leads to cell cycle blockage and apoptosis via p21
Waf1/Cip1
and p19
INK4d
upregulation in hepatocellular carcinoma
. Cell Proliferation 51:3, pages e12447.
Crossref
Crossref
Yu-Ju Chu, Hwai-I Yang, Hui-Chen Wu, Mei-Hsuan Lee, Jessica Liu, Li-Yu Wang, Sheng-Nan Lu, Chin-Lan Jen, San-Lin You, Regina M. Santella & Chien-Jen Chen. (2018) Aflatoxin B1 exposure increases the risk of hepatocellular carcinoma associated with hepatitis C virus infection or alcohol consumption. European Journal of Cancer 94, pages 37-46.
Crossref
Crossref
Nathan A. Berger. (2018) Young Adult Cancer: Influence of the Obesity Pandemic. Obesity 26:4, pages 641-650.
Crossref
Crossref
Cheng Zhang & Jiamin Zhang. (2018) Decreased expression of microRNA-223 promotes cell proliferation in hepatocellular carcinoma cells via the insulin-like growth factor-1 signaling pathway. Experimental and Therapeutic Medicine.
Crossref
Crossref
Seung-Hun Kim, Wen-Hsing Wang, Jing-Ping Wang, Chang-Heng Hsieh & Kang Fang. (2018) Teroxirone suppresses growth and motility of human hepatocellular carcinoma cells. Biomedicine & Pharmacotherapy 99, pages 997-1008.
Crossref
Crossref
Arnolfo Petruzziello. (2018) Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma. The Open Virology Journal 12:1, pages 26-32.
Crossref
Crossref
Ayman N. Menesy, Nancy A. Ahmed, Mohamed M. Elaraman & Ahmed H. AbdelFattah. (2018) Golgi protein 73 versus serum α-fetoprotein as tumor markers for hepatocellular carcinoma in patients with hepatitis C cirrhosis. Egyptian Liver Journal 8:1, pages 17-22.
Crossref
Crossref
William B. Coleman. 2018. Molecular Pathology. Molecular Pathology
71
97
.
Lingfeng Wan, Xin Yuan, Mantian Liu & Boyu Xue. (2017) miRNA-223-3p regulates NLRP3 to promote apoptosis and inhibit proliferation of hep3B cells. Experimental and Therapeutic Medicine.
Crossref
Crossref
Qinghai Guan, Zhiqiang Chen, Qiangpu Chen & Xuting Zhi. (2017) XRCC1 and XPD polymorphisms and their relation to the clinical course in hepatocarcinoma patients. Oncology Letters 14:3, pages 2783-2788.
Crossref
Crossref
Andrej Khandoga, Moritz Drefs, Markus Schoenberg, Tobias Schiergens, Katharina Frenes, Mark op den Winkel, Christoph Trumm, Martin K. Angele, Markus Guba, Jens Werner & Markus Rentsch. (2017) Differential significance of early surgical complications for acute and long-term recurrence-free survival following surgical resection of hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 29:9, pages 1045-1053.
Crossref
Crossref
Bright Nsokolo, Anne Kanunga, Edford Sinkala, Kanekwa Zyambo, Dia Kumwenda, David Chama, Gabriel Muyinda, Michael Vinikoor, Samreen Ijaz, Richard Tedder, Ali Khalifa A Elmdaah, Meleri Jones, Clarence Chiluba, Victor Mudenda, Robert D Goldin, Graham Foster & Paul Kelly. (2017) Stage of disease in hepatitis B virus infection in Zambian adults is associated with large cell change but not well defined using classic biomarkers. Transactions of The Royal Society of Tropical Medicine and Hygiene 111:9, pages 425-432.
Crossref
Crossref
Yi Cao, Ruisheng Ke, Shaohu Wang, Xu Zhu, Jianwei Chen, Chao Huang, Yi Jiang & Lizhi Lv. (2017) DNA topoisomerase IIα and Ki67 are prognostic factors in patients with hepatocellular carcinoma. Oncology Letters 13:6, pages 4109-4116.
Crossref
Crossref
Ran Xue, Qinghua Meng, Juan Li, Jiliang Feng & Hanping Shi. (2016) Worse or better?—Cirrhosis with hepatocellular carcinoma. Medical Hypotheses 97, pages 85-87.
Crossref
Crossref
Partha Pratim Bose, Gautam Mandal, Dharmendra Kumar, Ajay Duseja & Bishnu Pada Chatterjee. (2016) Visual detection of serum asialohaptoglobin by plasmonic sandwich ELLSA – a new platform for cirrhosis diagnosis. The Analyst 141:1, pages 76-84.
Crossref
Crossref
Danijel Galun. (2015) Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols. World Journal of Hepatology 7:20, pages 2274.
Crossref
Crossref